Ascendis Pharma Europe A/S
CVR 44420449 · Public limited company (A/S) · Active · Low risk
Ascendis Pharma Europe A/S is a Public limited company (A/S), founded on , based in Hellerup. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 940k and a net result of DKK 892k. CEO: Henrik Bolgan Thomsen.
Bankruptcy risk for Ascendis Pharma Europe A/S
0.4 × the average (1.41%) · higher risk than 59% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44420449
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (2 years)
- Address
- c/o Ascendis Pharma A/S, Tuborg Boulevard 12
2900 Hellerup - Municipality
- Gentofte
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 400k
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 2.8% |
| Current ratio | 104% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 224 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 34.9m | DKK 27k |
| Net profit | DKK 892k | DKK -5,000 |
| Equity | DKK 940k | DKK 49k |
| Total assets | DKK 34.0m | DKK 80k |
| Cash | DKK 18.6m | – |
| Short-term debt | DKK 32.8m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 90 | ||
| 6 Nov 2023 – 31 Dec 2024 | 126 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Henrik Bolgan Thomsen | Current | |
| Board | Michael Wolff Jensen | Current | |
| Board | Jan Møller Mikkelsen | Current | |
| Board | Anni Lotte Kirstine Pedersen | Current | |
| Owner (100%) | ASCENDIS PHARMA A/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | ASCENDIS PHARMA A/S | Current |
The CEOs' other companies
Henrik Bolgan Thomsen – 1 other companies
- TECHMEDIA ApS Active
Address history (0 moves)
| c/o Ascendis Pharma A/S, Tuborg Boulevard 12, 2900 Hellerup |
Other companies at the same address
- AFV-SELSKABET AF 8. JULI 2009 ApS Bankrupt
- AFVIKLINGSSELSKABET AF DEN 8. MAJ 2006 ApS Bankrupt
- AFVIKLINGSSELSKABET AF DEN 8. MAJ 2006 HOLDINGS ApS Bankrupt
- ANPARTSSELSKABET 11. MAJ 2006 Bankrupt
- ANPARTSSELSKABET AF 3.2.2004 Bankrupt
- All about IT Europe ApS Bankrupt
- ApS AF 9. NOVEMBER 2006 GENTOFTE Bankrupt
- B18 DANMARK ApS Bankrupt
- BROBY OVERDREV, EJENDOMSANPARTSSELSKAB Bankrupt
- BogM IT ApS Bankrupt
- Boligfonden LIAB ApS Bankrupt
- Brdr. Daugaard ApS Bankrupt
- Bygge Mester ApS Bankrupt
- CAMANN ApS Bankrupt
- CARCARE-EUROPE ApS Bankrupt
- CCE CAPITAL S.M.B.A. Bankrupt
- CID ApS Bankrupt
- CONSULTING LEAGUE ADVISORY ApS Bankrupt
- Clear Quality Holding IVS Bankrupt
- DK Accounting ApS Bankrupt
- DK Legal Advice ApS Bankrupt
- DKL 13 ApS Bankrupt
- DKL 15 ApS Bankrupt
- DKL 16 ApS Bankrupt
- DKL 17 ApS Bankrupt
Similar companies in Gentofte
- GastroBiome Delivery ApS Charlottenlund
- BioAgeDiagnostics ApS Charlottenlund
- MC ASPA ApS Charlottenlund
- Resqsupply ApS Gentofte
- Circius Pharma ApS Hellerup
- Valida Health ApS Hellerup
- Cordane International ApS Hellerup
- AJB Consult ApS Hellerup
- Chr. Olesen Pharma Latin A/S Gentofte
- Winmed A/S Hellerup
- Novivitae ApS Gentofte
- Inviocare Hellerup ApS Hellerup
Questions and answers about Ascendis Pharma Europe A/S
Has Ascendis Pharma Europe A/S gone bankrupt?
No, Ascendis Pharma Europe A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Ascendis Pharma Europe A/S?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Ascendis Pharma Europe A/S?
Henrik Bolgan Thomsen is the CEO of Ascendis Pharma Europe A/S.
Who is the auditor of Ascendis Pharma Europe A/S?
Ascendis Pharma Europe A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Ascendis Pharma Europe A/S founded?
Ascendis Pharma Europe A/S was founded on 6 November 2023.
What is the equity of Ascendis Pharma Europe A/S?
Equity was DKK 940k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.